| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6824282 | Schizophrenia Research | 2015 | 6 Pages |
Abstract
P50 deficits appear to be associated with the pre-clinical phase of psychosis. However, due to the limitations of the study and its sample size, replication in an independent cohort is necessary, to clarify the role of P50 deficits in illness progression and whether this inexpensive and non-invasive EEG marker could be of clinical value in the prediction of psychosis outcomes amongst populations at risk.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Madiha Shaikh, Anirban Dutt, Matthew R. Broome, Alberto G. Vozmediano, Siri Ranlund, Alvaro Diez, Olalla Caseiro, Julia Lappin, Susan Amankwa, Francesco Carletti, Paolo Fusar-Poli, Muriel Walshe, Mei-Hua Hall, Oliver Howes, Lyn Ellett, Robin M. Murray,